Skip to main content
. 2011 Aug 26;174(8):893–900. doi: 10.1093/aje/kwr171

Table 4.

Association Between Plasma Perfluoroalkyl Chemical Level and Chronic Kidney Disease, National Health and Nutrition Examination Survey, 1999–2008

Plasma Perfluoroalkyl Chemical Level Unweighted Sample Size (No. of Subjects) Chronic Kidney Disease, Weighted % Age- and Sex-Adjusted Odds Ratio
Multivariable-Adjusted Odds Ratioa
OR 95% CI OR 95% CI
Perfluorooctanoic acid
    Quartile 1 (<2.8 ng/mL) 1,176 4.9 1 Referent 1 Referent
    Quartile 2 (2.8–4.1 ng/mL) 1,141 4.8 0.89 0.61, 1.31 0.83 0.55, 1.24
    Quartile 3 (4.2–5.9 ng/mL) 1,141 6.4 1.27 0.77, 2.10 1.24 0.75, 2.05
    Quartile 4 (>5.9 ng/mL) 1,129 7.7 1.74 1.06, 2.84 1.73 1.04, 2.88
        P for trend 0.013 0.015
Perfluorooctane sulfonate
    Quartile 1 (<11.7 ng/mL) 1,152 3.7 1 Referent 1 Referent
    Quartile 2 (11.7–18.7 ng/mL) 1,151 4.7 1.13 0.63, 2.03 1.12 0.64, 1.99
    Quartile 3 (18.8–29.5 ng/mL) 1,137 6.9 1.55 0.87, 2.75 1.53 0.87, 2.67
    Quartile 4 (>29.5 ng/mL) 1,147 9.3 1.83 1.02, 3.28 1.82 1.01, 3.27
        P for trend 0.016 0.019

Abbreviations: CI, confidence interval; OR, odds ratio.

a

Adjusted for age (20–44, 45–64, or >64 years), sex (male or female), race/ethnicity (non-Hispanic white, non-Hispanic black, Mexican-American, or other), educational level (less than high school, high school graduate, or postsecondary education), smoking status (never, former, or current smoker), alcohol consumption (nondrinker, moderate drinker, or heavy drinker), body mass index category (normal or overweight/obese), systolic blood pressure (in mm Hg), diastolic blood pressure (in mm Hg), diabetes (absent or present), serum total cholesterol level (in mg/dL), and glycohemoglobin (%).